Illinois CancerCare Galesburg — Galesburg, Illinois

Illinois CancerCare Galesburg is a clinical research site located in Galesburg, Illinois, United States 61401.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Illinois CancerCare Galesburg has participated in 31 clinical trials with 2 currently active.

Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare Galesburg?

Illinois CancerCare Galesburg has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare Galesburg conducted?

Illinois CancerCare Galesburg has 31 clinical trials on record, with 2 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Is Illinois CancerCare Galesburg accredited by Crixeo Health?

Yes — Illinois CancerCare Galesburg holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Illinois CancerCare Galesburg?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.